CART-007, an anti-CD7 CAR T-cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ...

These sort of "living drugs"—T-cells modified to expand, recognize and attack cancer cells within the body—offer ... For children with acute lymphoblastic leukemia (ALL), measurable residual ...

Chronic lymphocytic leukemia (CLL) is a type of cancer ... complete blood count and blood cell exam or flow cytometry. During a complete blood count and blood cell exam, also known as peripheral ...

A new study identifies potential immune profile differences in patients with chronic lymphocytic ... flow cytometry. They found a significant increase in the proportion of cycling CD8+ T cells ...

The chimeric antigen receptor T-cell therapy obecabtagene autoleucel received approval to treat patients with relapsed or ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults. Obe-cel is a CD19-directed genetically modified autologous T cell immunotherapy that ...

The FDA approved obecabtagene autoleucel for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia.